BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28874394)

  • 1. Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms.
    Guerin C; Romanet P; Taieb D; Brue T; Lacroix A; Sebag F; Barlier A; Castinetti F
    Endocr Relat Cancer; 2018 Feb; 25(2):T15-T28. PubMed ID: 28874394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiple endocrine neoplasia type 2].
    Niccoli-Sire P; Conte-Devolx B
    Ann Endocrinol (Paris); 2007 Oct; 68(5):317-24. PubMed ID: 17626779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 2.
    Lodish M
    Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.
    Thosani S; Ayala-Ramirez M; Palmer L; Hu MI; Rich T; Gagel RF; Cote G; Waguespack SG; Habra MA; Jimenez C
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1813-9. PubMed ID: 24030942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives.
    Amodru V; Taieb D; Guerin C; Romanet P; Paladino N; Brue T; Cuny T; Barlier A; Sebag F; Castinetti F
    Endocrine; 2020 Sep; 69(3):496-503. PubMed ID: 32388798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of RET genetic variants in MEN2-associated pheochromocytoma.
    Siqueira DR; Ceolin L; Ferreira CV; Romitti M; Maia SC; Maciel LM; Maia AL
    Eur J Endocrinol; 2014 Jun; 170(6):821-8. PubMed ID: 24616415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia, the old and the new: a mini review.
    Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
    G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
    Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
    Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
    Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
    World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The trends in early precision diagnosis and treatment strategies of multiple endocrine neoplasia type 2].
    Qi XP; Jin B
    Zhonghua Wai Ke Za Zhi; 2022 Nov; 60(11):973-980. PubMed ID: 36323578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of multiple endocrine neoplasia].
    Conte-Devolx B; Niccoli P;
    Bull Acad Natl Med; 2010 Jan; 194(1):69-78; discussion 78-9. PubMed ID: 20669560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple endocrine neoplasia type IIa (MEN2A)].
    Hashizume K; Suzuki S; Shigematsu S; Takeda T
    Nihon Rinsho; 2006 Sep; Suppl 3():337-42. PubMed ID: 17022559
    [No Abstract]   [Full Text] [Related]  

  • 14. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M; Pinson S; Guillaud-Bataille M; Gimenez-Roqueplo AP; Carrie A; Barbu V; Pigny P; Bezieau S; Rey JM; Delvincourt C; Giraud S; Veyrat-Durebex C; Saulnier P; Bouzamondo N; Chabbert M; Blin J; Mohamed A; Romanet P; Borson-Chazot F; Rohmer V; Barlier A; Mirebeau-Prunier D
    Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 2.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Tognarini I; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Nov; 1():45. PubMed ID: 17105651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.
    Castinetti F; Taieb D; Henry JF; Walz M; Guerin C; Brue T; Conte-Devolx B; Neumann HP; Sebag F
    Eur J Endocrinol; 2016 Jan; 174(1):R9-18. PubMed ID: 26297495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 2 (MEN 2).
    Frank-Raue K; Raue F
    Eur J Cancer; 2009 Sep; 45 Suppl 1():267-73. PubMed ID: 19775624
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
    Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
    Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrathyroidal manifestations of multiple endocrine neoplasia type 2.
    Brauckhoff M; Gimm O
    Thyroid; 2009 Jun; 19(6):555-7. PubMed ID: 19499988
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors.
    Wells SA
    Endocr Relat Cancer; 2018 Feb; 25(2):T1-T13. PubMed ID: 29142004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.